CD274 and neoplasm: Moreover, currently available genomic or immunohistochemical expression patterns, such as PD-L1 expression, tumor mutational burden, and microsatellite instability, from tumor biopsies exhibit limited predictive value in clinical practice 10-14, underscoring the pressing need for robust biomarker identification that can reliably stratify patients and predict immunotherapy efficacy.